Associated Factors with Erectile Dysfunction in Hemodialysis Patients at Dr. Reksodiwiryo Hospital Padang
Abstract
Background: Erectile dysfunction (ED) is a common condition affecting a significant number of men worldwide, with its prevalence particularly high among patients with chronic kidney disease (CKD).
Objective: This study aims to investigate the association between ED and CKD in patients undergoing hemodialysis.
Methods: This study used a survey approach, designed with cross-sectional involving 24 male patients undergoing hemodialysis at the hospital from January to July 2024. Data were gathered using the IIEF-5 questionnaire as well as patient records. The severity of ED was classified based on IIEF-5 scores, and data analysis was conducted using SPSS.
Results: Most respondents (58.3%) were under 60 years old, with 58.3% having hemoglobin levels below 10 g/dL and 79.2% with a KT/V ratio under 1.8. ED prevalence was high at 95.8%, with severe ED affecting 54.2%. A significant correlation existed between KT/V and ED severity p<0.05, while hemoglobin levels showed no significant association p>0.05. The high prevalence of ED in CKD patients undergoing hemodialysis highlights the importance of regular screening and early intervention. The study indicates that sufficient hemodialysis, as measured by the Kt/V ratio, could be essential in reducing the severity of ED in this group. However, hemoglobin levels did not show a significant connection to ED severity, which contrasts with certain earlier research findings.
Conclusion: Erectile dysfunction is common among CKD patients undergoing hemodialysis, with insufficient dialysis being a key contributing factor. This highlights the need to maintain adequate dialysis to reduce the severity of ED in these individuals.
Downloads
References
2. Al-Qudimat A, Al-Zoubi R, Mahdi M, Talib R, Yassin A. Long-term testosterone therapy improves renal function in men with hypogonadism: A real-life prospective controlled registry. J Clin Nephrol Res. 2020;7(1):1095. doi:10.47739/2379-0652/1095
3. Navaneethan SD, Vecchio M, Johnson DW, Saglimbene V, Graziano G, Pellegrini F. Prevalence and correlates of self-reported sexual dysfunction in CKD: A meta-analysis of observational studies. Am J Kidney Dis. 2010;56(4):670–85. doi:10.1053/j.ajkd.2010.06.016
4. Mesquita JFP, Ramos TF, Mesquita FP, Netto JMB, Bastos MG, Figueiredo AA. Prevalence of erectile dysfunction in chronic renal disease patients on conservative treatment. Clinics. 2012;67(2):181–3. doi:10.6061/clinics/2012(02)15
5. Nassir A. Erectile dysfunction risk factors for patients entering dialysis programme. Andrologia. 2010;42(1):41–7. doi:10.1111/j.1439-0272.2009.00954.x
6. Chen TK, Knicely DH, Grams ME. Chronic kidney disease diagnosis and management: A review. JAMA. 2019;322(13):1294–1304. doi:10.1001/jama.2019.14745
7. Asai M, Kumakura S, Kikuchi M. Review of the efficacy of AST-120 (KREMEZIN®) on renal function in chronic kidney disease patients. Ren Fail. 2019;41(1):47–56. doi:10.1080/0886022x.2018.1561376
8. Malekmakan L, Shakeri S, Haghpanah S, Pakfetrat M, Sarvestani AS, Malekmakan A. Epidemiology of erectile dysfunction in hemodialysis patients using IIEF questionnaire. Saudi J Kidney Dis Transpl. 2011;22(2):232–6.
9. Hauk M, Kuhlmann MK, Riegel W, Köhler H. In vivo effects of dialysate flow rate on Kt/V in maintenance hemodialysis patients. Am J Kidney Dis. 2000;35(1):105–11. doi:10.1016/s0272-6386(00)70308-8
10. Naya Y, Soh J, Ochiai A, Mizutani Y, Ushijima S, Kamoi K. Significant decrease of the International Index of Erectile Function in male renal failure patients treated with hemodialysis. Int J Impot Res. 2002;14(3):172–7. doi:10.1038/sj.ijir.3900854
11. Arslan D, Aslan G, Sifil A, Çavdar C, Çelebi I, Gamsari T. Sexual dysfunction in male patients on hemodialysis: Assessment with the International Index of Erectile Function (IIEF). Int J Impot Res. 2002;14(6):539–42. doi:10.1038/sj.ijir.3900937
Copyright (c) 2025 Indonesian Journal of Kidney and Hypertension

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with Indonesian Journal of Kidney and Hypertension agree to the following terms:
- Authors retain copyright and grant Indonesian Journal of Kidney and Hypertension right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial License that allows others to remix, adapt, build upon the work non-commercially with an acknowledgment of the work’s authorship and initial publication in Indonesian Journal of Kidney and Hypertension.
- Authors are permitted to copy and redistribute the journal's published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Indonesian Journal of Kidney and Hypertension.




1.png)



